Topic Review
Vaccinations and Autoimmune Diseases
Vaccines represent one of the most effective measures of public health medicine, saving countless lives and preventing lifelong disabilities. Among the adverse reactions to vaccines, one of the most feared is the triggering of autoimmune diseases, which are a heterogeneous group of disorders characterized by dysregulation of the immune system. Currently, no mechanisms have been demonstrated that could explain the correlation between vaccination and the development of autoimmune diseases. Furthermore, epidemiological studies do not support the hypothesis that vaccines cause systemic autoimmune diseases. The only confirmed associations, although very rare, are those between the flu vaccine and Guillain-Barré syndrome, especially with old vaccine preparations, and measles-mumps-rubella (MMR) vaccine and thrombocytopenia. 
  • 918
  • 24 Nov 2021
Topic Review
EAPCRN
The East Asian Primary Care Research Network (EAPCRN), initially proposed by Professor Jae-Ho Lee who is the Chairman of the Korean Primary Care Research Group, was officially established during the 22nd World Organization of Family Doctors (WONCA) World Conference – "Primary Care in the Future: Professional Excellence" during 17-21 October 2018 in Seoul, South Korea. The EAPCRN inauguration seminar at WONCA Seoul 2018 was convened by Jae-Ho Lee (Korean Primary Care Research Group; The Catholic University of Korea) and co-convened by Harry H.X. Wang (Sun Yat-Sen University), Takuya Aoki (Kyoto University), and Chyi-Feng Jan (National Taiwan University).
  • 917
  • 05 Nov 2020
Topic Review
JNKs in Development of Disease
c-Jun N-terminal kinases (JNKs) have emerged as suitable therapeutic strategies. In fact, it has been demonstrated that some unspecific JNK inhibitors exert antidiabetic and neuroprotective effects, albeit they usually show high toxicity or lack therapeutic value. In this sense, natural specific JNK inhibitors, such as Licochalcone A, are promising candidates. Nonetheless, research on the understanding of the role of each of the JNKs remains mandatory in order to progress on the identification of new selective JNK isoform inhibitors. In the present review, a summary on the current gathered data on the role of JNKs in pathology is presented, as well as a discussion on their potential role in pathologies like epilepsy and metabolic-cognitive injury. Moreover, data on the effects of synthetic small molecule inhibitors that modulate JNK-dependent pathways in the brain and peripheral tissues is reviewed.
  • 917
  • 23 Oct 2020
Topic Review
Corneal Anatomy and Physiology
The cornea, known as the window of the eye, is optically transparent, including a special structure that is avascular anatomically. This dome-shaped and specialized tissue is located in the anterior part of the eye. Two major roles of the cornea are protecting the eye from harsh environments, and transmitting over 80% of light to inner portions. 
  • 916
  • 22 Dec 2022
Topic Review
Triple Overlap Syndrome (OSAHS-COPD-CHF)
Obstructive sleep apnea-hypopnea syndrome (OSAHS) and chronic obstructive pulmonary disease (COPD) are independently linked to an increase in cardiovascular disease (CVD). Only a few studies have been published linking the association between overlap syndrome and congestive heart failure (CHF). It is becoming increasingly clear through research that there is a strong connection between OSA, COPD, and CHF. 
  • 929
  • 06 Sep 2023
Topic Review
External Human–Machine Interface of AVs
In future urban traffic, it is more likely that automated vehicles (AVs) will operate not in separated traffic spaces but in so-called mixed traffic environments where different types of traffic participants interact. Therefore, AVs must be able to communicate with other traffic participants, e.g., pedestrians as vulnerable road users (VRUs), to solve ambiguous traffic situations. Taking current traffic communication patterns into account, a combination of implicit communication via the driving behavior (e.g., deceleration, position in lane) and explicit communication via an external Human–Machine Interface (eHMI) seems to be a promising approach. The eHMI consists of an external interface connected to the vehicle, which can transmit explicit signals enabling interaction between AVs and other TPs.
  • 915
  • 15 Aug 2021
Topic Review
Ghrelin
Ghrelin is an endogenous ligand for the ghrelin receptor, previously known as the growth hormone secretagogue receptor. This hormone is mainly produced by endocrine cells present in the gastric mucosa. The ghrelin-producing cells are also present in other organs of the body, mainly in the digestive system, but in much smaller amount. Ghrelin exhibits a broad spectrum of physiological effects, such as stimulation of growth hormone secretion, gastric secretion, gastrointestinal motility, and food intake, as well as regulation of glucose homeostasis and bone formation, and inhibition of inflammatory processes.
  • 915
  • 21 Oct 2021
Topic Review
Viral Vectors for Gene Delivery
Over the course of millions of years, viruses have evolved and adapted to changes in the biological environment which has allowed them to survive and replicate in host cells. Using this feature of viruses, gene therapy research has developed new approaches utilizing viruses and their different genomes as carriers and vectors for the delivery of genes, nucleic acids, and other genetic material to cell target sites.
  • 915
  • 24 Aug 2022
Topic Review
Carica papaya Leaf Juice for Dengue
Dengue, an Aedes mosquito-borne viral infection, has become a public health risk that demands the world’s focus, especially in tropical countries. Despite of the life-threatening complication, there are still no specific antiviral medications for dengue infection. This situation highlight the research need in identifying potent compounds with promising anti-dengue activities. Therefore, a scoping review was conducted to gather and highlight the available scientific evidence for the use of C. papaya leaf, particularly using juice form, as a complementary method in treating dengue infection.
  • 914
  • 21 Apr 2022
Topic Review
SGLT2 Inhibitors
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a new class of oral glucose-lowering agents. Apart from their glucose-lowering effects, large clinical trials assessing certain SGLT2 inhibitors have revealed cardiac and renal protective effects in non-diabetic patients. These excellent outcomes motivated scientists and clinical professionals to revisit their underlying mechanisms. In addition to the heart and kidney, redox homeostasis is crucial in several human diseases, including liver diseases, neural disorders, and cancers, with accumulating preclinical studies demonstrating the therapeutic benefits of SGLT2 inhibitors.
  • 914
  • 18 Apr 2022
  • Page
  • of
  • 1352
Video Production Service